Last chance to save on Digiday Publishing Summit passes is February 9
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
What Amazon’s proposed big-box store could mean for Walmart
Public documents published by the Village of Orland Park described a 225,000-square-foot Amazon store that would sell a range of products.
Future of Marketing Briefing: AI companies are staffing up for a reputation fight
AI has an image problem, which explains why the industry is suddenly investing so much energy in who gets to tell its story.
Albertsons is putting digital screens for ads in more than a third of its stores
The retail giant has seen enough success in its digital screen network to begin a rollout in 800 of its 2,200-plus stores in 2026.